Abvc Biopharma, Inc. financial data

Symbol
ABVC on Nasdaq
Location
Fremont, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 39.9 % +24.5%
Debt-to-equity 106 % -72.8%
Return On Equity -62.2 % +80.9%
Return On Assets -33.9 % +41.2%
Operating Margin -923 % +79.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 24.3M shares +87.3%
Common Stock, Shares, Outstanding 24.2M shares +90.3%
Entity Public Float 7.2M USD +38.5%
Common Stock, Value, Issued 24.2K USD +90.3%
Weighted Average Number of Shares Outstanding, Basic 23.3M shares +87.5%
Weighted Average Number of Shares Outstanding, Diluted 23.3M shares +87.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 796K USD +104%
Cost of Revenue 763 USD -99.7%
Research and Development Expense 124K USD -43.5%
Operating Income (Loss) -4.86M USD -7.72%
Nonoperating Income (Expense) -476K USD +18.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.34M USD -4.69%
Income Tax Expense (Benefit) 527 USD +48.5%
Net Income (Loss) Attributable to Parent -5.08M USD -11.5%
Earnings Per Share, Basic 0 USD/shares -73.3%
Earnings Per Share, Diluted 0 USD/shares -73.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 192K USD +39.8%
Accounts Receivable, after Allowance for Credit Loss, Current 1.53K USD -0.07%
Inventory, Net 11.5K USD
Assets, Current 4.07M USD +87.6%
Deferred Income Tax Assets, Net 34.3K USD -96.6%
Property, Plant and Equipment, Net 12.1M USD +2168%
Operating Lease, Right-of-Use Asset 369K USD -27.3%
Other Assets, Noncurrent 117K USD
Assets 21.2M USD +172%
Employee-related Liabilities, Current 155K USD +72.2%
Accrued Liabilities, Current 3.7M USD +27%
Contract with Customer, Liability, Current 81.1K USD +2.03%
Liabilities, Current 6.51M USD +4.17%
Contract with Customer, Liability, Noncurrent 296K USD
Operating Lease, Liability, Noncurrent 164K USD +15.4%
Liabilities 6.68M USD +3.77%
Accumulated Other Comprehensive Income (Loss), Net of Tax 487K USD +5.59%
Retained Earnings (Accumulated Deficit) -73.3M USD -3.89%
Stockholders' Equity Attributable to Parent 12.1M USD +634%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 14.5M USD +984%
Liabilities and Equity 21.2M USD +172%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -540K USD +43.5%
Net Cash Provided by (Used in) Financing Activities 429K USD -53.6%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 24.2M shares +90.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -104K USD -80.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 854K USD +10.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.23K USD -8.24%
Deferred Tax Assets, Valuation Allowance 6.91M USD +10.1%
Deferred Tax Assets, Gross 6.91M USD +10.1%
Operating Lease, Liability 369K USD -27.3%
Depreciation 30K USD +2.65%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5.05M USD -9.64%
Lessee, Operating Lease, Liability, to be Paid 378K USD -25.6%
Property, Plant and Equipment, Gross 15.4M USD +36.9%
Operating Lease, Liability, Current 199K USD -45.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 55.6K USD -2.29%
Lessee, Operating Lease, Liability, to be Paid, Year One 119K USD -66.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure +435%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.33K USD +632%
Lessee, Operating Lease, Liability, to be Paid, Year Three 50.9K USD
Deferred Tax Assets, Operating Loss Carryforwards 6M USD
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 50.9K USD
Operating Lease, Payments 117K USD +18.9%
Additional Paid in Capital 93.1M USD +19%
Depreciation, Depletion and Amortization 27.4K USD +15.4%
Share-based Payment Arrangement, Expense 451K USD -50%
Interest Expense 1.44M USD +333%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%